Genus Sustainability Profile
Genus plc, commonly referred to as Genus, is a leading global biotechnology company headquartered in Great Britain. Founded in 1939, Genus has established itself as a pioneer in the animal genetics industry, focusing on improving livestock productivity and health through innovative breeding solutions. With major operations across Europe, North America, and Asia, Genus offers a diverse range of products and services, including advanced genetic technologies and breeding programmes for cattle, pigs, and poultry. Their unique approach combines cutting-edge science with a commitment to sustainability, positioning them as a market leader in animal breeding and genetics. Notable achievements include significant advancements in genomic selection and a strong emphasis on animal welfare, which have solidified Genus's reputation as a trusted partner in the agricultural sector.
DitchCarbon Score
How does Genus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genus's score of 33 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Genus's reported carbon emissions
In 2025, Genus, headquartered in Great Britain, reported total carbon emissions of approximately 68101000 kg CO2e for Scope 1, 15567000 kg CO2e for Scope 2, and 190358000 kg CO2e for Scope 3, resulting in a combined total of about 83668000 kg CO2e for Scope 1 and 2. In 2024, the emissions were slightly lower, with Scope 1 at 66977000 kg CO2e, Scope 2 at 11991000 kg CO2e, and Scope 3 at 233789000 kg CO2e, leading to a total of approximately 78968000 kg CO2e for Scope 1 and 2. Genus has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further development in their sustainability strategy. The emissions data is sourced directly from Genus plc, with no cascading from a parent organization. Overall, while Genus has made strides in reporting their emissions, the lack of reduction initiatives indicates an opportunity for improvement in their climate action efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Scope 1 | 74,339,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 9,710,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 |
How Carbon Intensive is Genus's Industry?
How Carbon Intensive is Genus's Location?
Genus's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Genus has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Boehringer Ingelheim Pharmaceuticals, Inc.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.